Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-01-10
2006-01-10
Tate, Christopher R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S019300, C530S330000, C530S331000, C560S024000, C560S159000
Reexamination Certificate
active
06984626
ABSTRACT:
A class of compounds is disclosed which are diasteroisomers of a known class of protease inhibitors. The compound inhibit gamma-secretase, and find use in the treatment of and/or prevention of Alzheimer's disease.
REFERENCES:
patent: 5703129 (1997-12-01), Felsenstein et al.
patent: 6252041 (2001-06-01), Yanai et al.
patent: 2076204 (1993-02-01), None
patent: 0356223 (1990-02-01), None
patent: WO 94/13319 (1994-06-01), None
Nadin Alan John
Stevenson Graeme Irvine
Cordero Garcia Marcela M
Merck Sharp & Dohme Ltd.
Tate Christopher R.
Todaro John C.
Winokur Melvin
LandOfFree
Gamma-secretase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gamma-secretase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gamma-secretase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3567073